Full name
MW - PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
86.91.A - Diagnostic imaging activities
86.91.B - Medical laboratory activities
86.93.Z - Psychology and psychotherapy activities, excluding medical activities
86.95.Z - Physiotherapy activities
86.99.A - Pharmaceutical care
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 0,6 | 0,7 | 15,7 |
EBITDA | 0,9 | 0,8 | 0,8 | 4,6 |
Short time liabilities | 1,5 | 1,9 | 2,1 | 10,9 |
Equity capital | 1 | 1,6 | 2,2 | 37,3 |
Operating profit (EBIT) | 0,8 | 0,7 | 0,7 | 6 |
Assets | 2,6 | 3,5 | 4,2 | 22,9 |
Net profit (loss) | 0,8 | 0,6 | 0,6 | 4,3 |
Cash | 0,4 | 0,6 | 0,7 | 25,4 |
Net income from sale | 15 | 18,3 | 19,7 | 7,6 |
Liabilities and provisions for liabilities | 1,6 | 1,9 | 2,1 | 10,9 |
Working assets | 2,5 | 3,4 | 4,2 | 22,8 |
Depreciation | 0,1 | 0,1 | 0,1 | -6,6 |
% | % | % | p.p. | |
Profitability of capital | 78,4 | 35,7 | 27,2 | -8,5 |
Equity capital to total assets | 38,8 | 45,5 | 50,8 | 5,3 |
Gross profit margin | 5,3 | 3,3 | 3,6 | 0,3 |
EBITDA Margin | 5,7 | 4,1 | 4 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 37 | 39 | 2 |
Current financial liquidity indicator | 1.686270833015442 | 1.8059784173965454 | 1.9997752904891968 | 0,2 |
Net dept to EBITDA | -0.22607675194740295 | -0.6826257109642029 | -0.9422795176506042 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane